Product development in the biomedical area presents unique challenges that need to be addressed to efficiently satisfy strict regulatory requirements and to successfully advance products to approval for marketing. Biomedical engineers need a broad understanding of these challenges as the main components of product development are complex and interdependent. Development of good manufacturing and quality control processes, preclinical and clinical validation of product safety and efficacy, and regulatory filings, are each progressive and interdependent processes. This UoS will provide a broad understanding of regulatory requirements for biomedical product development, with particular emphasis on the dependence of each component on the development of processes and control systems that conform to Good Manufacturing Practice. This UoS assumes prior knowledge of cell biology and chemistry and builds on that foundation to elaborate on the important aspects of biomedical product development.
Unit details and rules
Academic unit | Biomedical Engineering |
---|---|
Credit points | 6 |
Prerequisites
?
|
None |
Corequisites
?
|
None |
Prohibitions
?
|
AMME4990 OR BMET4990 OR AMME5990 OR AMME9990 |
Assumed knowledge
?
|
1000 level chemistry, 2000 level biology, and specific knowledge of cell biology at least at the1000 level, and preferably at the 2000 level. |
Available to study abroad and exchange students | No |
Teaching staff
Coordinator | Colin Dunstan, colin.dunstan@sydney.edu.au |
---|---|
Lecturer(s) | Colin Dunstan, colin.dunstan@sydney.edu.au |
Tutor(s) | Md Musharraf Hossain, m.hossain@sydney.edu.au |